These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32706146)

  • 1. Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review.
    Sekiguchi N; Kubota S; Noguchi T; Fukushima T; Kobayashi T; Kanda S; Koizumi T; Miyake T; Shirai T; Okuyama R
    J Dermatol; 2020 Nov; 47(11):1276-1279. PubMed ID: 32706146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
    Bartoletti M; Mazzeo R; De Scordilli M; Del Fabro A; Vitale MG; Bortot L; Nicoloso MS; Corsetti S; Bonotto M; Scalone S; Giorda G; Sorio R; Andreetta C; Meacci ML; De Vivo R; Fasola G; Sopracordevole F; Puglisi F
    Int J Gynecol Cancer; 2020 Nov; 30(11):1672-1677. PubMed ID: 32998859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful human epidermal growth receptor 2-targeted therapy beyond disease progression for extramammary Paget's disease.
    Watanabe S; Takeda M; Takahama T; Iwasa T; Tsurutani J; Tanizaki J; Shimizu T; Sakai K; Wada Y; Isogai N; Nishio K; Nakagawa K
    Invest New Drugs; 2016 Jun; 34(3):394-6. PubMed ID: 26856856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: A case report and review of the literature.
    Ichiyama T; Gomi D; Fukushima T; Kobayashi T; Sekiguchi N; Sakamoto A; Sasaki S; Mamiya K; Koizumi T; Hama Y
    Mol Clin Oncol; 2017 Nov; 7(5):763-766. PubMed ID: 29181166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
    Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M
    J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy.
    Hanawa F; Inozume T; Harada K; Kawamura T; Shibagaki N; Shimada S
    Case Rep Dermatol; 2011 Sep; 3(3):223-7. PubMed ID: 22135629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extramammary Paget's disease: analysis of growth signal pathway from the human epidermal growth factor receptor 2 protein.
    Ogawa T; Nagashima Y; Wada H; Akimoto K; Chiba Y; Nagatani T; Inayama Y; Yao M; Aoki I; Ikezawa Z
    Hum Pathol; 2005 Dec; 36(12):1273-80. PubMed ID: 16311120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).
    Hirai I; Tanese K; Nakamura Y; Fukuda K; Ouchi T; Hayashida T; Kameyama K; Abe T; Amagai M; Funakoshi T
    Oncologist; 2024 Sep; 29(9):e1201-e1208. PubMed ID: 38823035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
    Liegl B; Horn LC; Moinfar F
    Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06.
    Sohn BS; Kim J; Kim M; Hong JY; Lee J; Park SE; Kim H; Lee HJ; Kang EJ; Lee SI; Lee IH; Huh SJ; Jo J; Kim HY
    Cancer Med; 2023 Jul; 12(14):15159-15175. PubMed ID: 37264748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential somatic mutations upon secondary anti-HER2 treatment resistance in metastatic ERBB2
    Nordmann TM; Messerli-Odermatt O; Meier L; Micaletto S; Coppetti T; Nägeli M; Kamarachev J; Kudura K; Freiberger SN; Rordorf T; Mangana J; Braun R; Dummer R
    Oncotarget; 2019 Nov; 10(62):6647-6650. PubMed ID: 31803359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the methods used to detect HER2-positive advanced extramammary Paget's disease.
    Hirai I; Tanese K; Nakamura Y; Otsuka A; Fujisawa Y; Yamamoto Y; Hata H; Fujimura T; Matsushita S; Yoshino K; Kameyama K; Amagai M; Funakoshi T
    Med Oncol; 2018 May; 35(6):92. PubMed ID: 29744813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.
    Lu X; Zhang P; Zhu Y; Ye D
    Oncol Lett; 2019 Mar; 17(3):2677-2686. PubMed ID: 30854041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 oncogene amplification in extramammary Paget's disease.
    Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
    Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease.
    Reich O; Liegl B; Tamussino K; Regauer S
    Mod Pathol; 2005 Mar; 18(3):354-7. PubMed ID: 15272283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramammary Paget's Disease in Two Brothers.
    Zhang X; Jin W; Zhu H; Yu H
    Indian J Dermatol; 2015; 60(4):423. PubMed ID: 26288451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease.
    Takata M; Fujimoto A; Aoki H; Hatta N; Ooi A; Takehara K
    J Invest Dermatol; 1999 Aug; 113(2):258-62. PubMed ID: 10469313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Complete Response and Survival in Metastatic Extramammary Paget's Disease Treated With Trastuzumab Plus Paclitaxel: A Case Report.
    Chilelli MG; Signorelli C; Giron Berrios JR; Raso A; Nelli F; Ruggeri EM
    Cureus; 2024 Apr; 16(4):e58924. PubMed ID: 38800219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome sequencing of HER2-positive metastatic extramammary Paget's disease: a case report.
    Lim BY; Guo Z; Lim JQ; Ko TK; Lee ECY; Kannan B; Lee JY; Lim AH; Li Z; Ng CC; Busmanis I; Chan JY
    Orphanet J Rare Dis; 2024 Jun; 19(1):223. PubMed ID: 38831459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic Extramammary Paget's Disease with near-complete response to trastuzumab and paclitaxel therapy.
    Dao A; Chung AD; Gray G
    Arch Gynecol Obstet; 2024 Jul; 310(1):595-597. PubMed ID: 38494513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.